132 related articles for article (PubMed ID: 21784632)
21. Synthesis and biological evaluation of inhibitors of thymidine monophosphate kinase from Bacillus anthracis.
Byun Y; Vogel SR; Phipps AJ; Carnrot C; Eriksson S; Tiwari R; Tjarks W
Nucleosides Nucleotides Nucleic Acids; 2008 Mar; 27(3):244-60. PubMed ID: 18260009
[TBL] [Abstract][Full Text] [Related]
22. Baulamycins A and B, broad-spectrum antibiotics identified as inhibitors of siderophore biosynthesis in Staphylococcus aureus and Bacillus anthracis.
Tripathi A; Schofield MM; Chlipala GE; Schultz PJ; Yim I; Newmister SA; Nusca TD; Scaglione JB; Hanna PC; Tamayo-Castillo G; Sherman DH
J Am Chem Soc; 2014 Jan; 136(4):1579-86. PubMed ID: 24401083
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Bacillus anthracis spore outgrowth by nisin.
Gut IM; Prouty AM; Ballard JD; van der Donk WA; Blanke SR
Antimicrob Agents Chemother; 2008 Dec; 52(12):4281-8. PubMed ID: 18809941
[TBL] [Abstract][Full Text] [Related]
24. Acyl-sulfamates target the essential glycerol-phosphate acyltransferase (PlsY) in Gram-positive bacteria.
Cherian PT; Yao J; Leonardi R; Maddox MM; Luna VA; Rock CO; Lee RE
Bioorg Med Chem; 2012 Aug; 20(16):4985-94. PubMed ID: 22795901
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
Zhang HJ; Qin X; Liu K; Zhu DD; Wang XM; Zhu HL
Bioorg Med Chem; 2011 Sep; 19(18):5708-15. PubMed ID: 21872479
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antibacterial activity of peptide deformylase inhibitors.
Huntington KM; Yi T; Wei Y; Pei D
Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004
[TBL] [Abstract][Full Text] [Related]
27. Tertiary amides of Salinomycin: A new group of antibacterial agents against Bacillus anthracis and methicillin-resistant Staphylococcus epidermidis.
Stefańska J; Antoszczak M; Stępień K; Bartoszcze M; Mirski T; Huczyński A
Bioorg Med Chem Lett; 2015; 25(10):2082-8. PubMed ID: 25891104
[TBL] [Abstract][Full Text] [Related]
28. Antibacterial evaluation and mode of action study of BIMQ, a novel bacterial cell division inhibitor.
Sun N; Li M; Cai S; Li Y; Chen C; Zheng Y; Li X; Fang Z; Lv H; Lu YJ
Biochem Biophys Res Commun; 2019 Jul; 514(4):1224-1230. PubMed ID: 31109649
[TBL] [Abstract][Full Text] [Related]
29. The lipopeptides mycosubtilin and surfactin enhance spreading of Bacillus subtilis strains by their surface-active properties.
Leclère V; Marti R; Béchet M; Fickers P; Jacques P
Arch Microbiol; 2006 Dec; 186(6):475-83. PubMed ID: 16964493
[TBL] [Abstract][Full Text] [Related]
30. In vivo characterization of an Hfq protein encoded by the Bacillus anthracis virulence plasmid pXO1.
Keefer AB; Asare EK; Pomerantsev AP; Moayeri M; Martens C; Porcella SF; Gottesman S; Leppla SH; Vrentas CE
BMC Microbiol; 2017 Mar; 17(1):63. PubMed ID: 28288571
[TBL] [Abstract][Full Text] [Related]
31. Development of a novel selective agar for the isolation and detection of Bacillus anthracis.
Rohde A; Papp S; Feige P; Grunow R; Kaspari O
J Appl Microbiol; 2020 Aug; 129(2):311-318. PubMed ID: 32052540
[TBL] [Abstract][Full Text] [Related]
32. N-thiolated beta-lactams: a new family of anti-Bacillus agents.
Turos E; Long TE; Heldreth B; Leslie JM; Reddy GS; Wang Y; Coates C; Konaklieva M; Dickey S; Lim DV; Alonso E; Gonzalez J
Bioorg Med Chem Lett; 2006 Apr; 16(8):2084-90. PubMed ID: 16473509
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Bacillus anthracis thymidine kinase as a potential target for the development of antibacterial nucleoside analogs.
Carnrot C; Vogel SR; Byun Y; Wang L; Tjarks W; Eriksson S; Phipps AJ
Biol Chem; 2006 Dec; 387(12):1575-81. PubMed ID: 17132103
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and molecular docking study of some 3,4-dihydrothieno[2,3-d]pyrimidine derivatives as potential antimicrobial agents.
Shaaban OG; Issa DAE; El-Tombary AA; Abd El Wahab SM; Abdel Wahab AE; Abdelwahab IA
Bioorg Chem; 2019 Jul; 88():102934. PubMed ID: 31026720
[TBL] [Abstract][Full Text] [Related]
35. Determining the efficacy of liquid sporicides against spores of Bacillus subtilis on a hard nonporous surface using the quantitative three step method: collaborative study.
Tomasino SF; Pines RM; Cottrill MP; Hamilton MA
J AOAC Int; 2008; 91(4):833-52. PubMed ID: 18727544
[TBL] [Abstract][Full Text] [Related]
36. Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete.
Jang KH; Nam SJ; Locke JB; Kauffman CA; Beatty DS; Paul LA; Fenical W
Angew Chem Int Ed Engl; 2013 Jul; 52(30):7822-4. PubMed ID: 23776159
[TBL] [Abstract][Full Text] [Related]
37. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Bacillus anthracis growth and virulence-gene expression by inhibitors of quorum-sensing.
Jones MB; Jani R; Ren D; Wood TK; Blaser MJ
J Infect Dis; 2005 Jun; 191(11):1881-8. PubMed ID: 15871122
[TBL] [Abstract][Full Text] [Related]
39. Potentiating 1-(2-hydroxypropyl)-2-styryl-5-nitroimidazole derivatives against antibacterial agents: design, synthesis and biology analysis.
Wang ZC; Duan YT; Qin YJ; Wang PF; Luo Y; Wen Q; Yang YA; Sun J; Hu Y; Sang YL; Zhu HL
Eur J Med Chem; 2013 Jul; 65():456-63. PubMed ID: 23770447
[TBL] [Abstract][Full Text] [Related]
40. Probing the ligand preferences of the three types of bacterial pantothenate kinase.
Guan J; Barnard L; Cresson J; Hoegl A; Chang JH; Strauss E; Auclair K
Bioorg Med Chem; 2018 Dec; 26(22):5896-5902. PubMed ID: 30429095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
